The estimated Net Worth of John Osteraas is at least $1.2 million dollars as of 6 May 2015. John Osteraas owns over 3,692 units of Exponent stock worth over $217,861 and over the last 18 years John sold EXPO stock worth over $982,248.
John has made over 10 trades of the Exponent stock since 2011, according to the Form 4 filled with the SEC. Most recently John sold 3,692 units of EXPO stock worth $320,244 on 6 May 2015.
The largest trade John's ever made was selling 4,016 units of Exponent stock on 26 February 2014 worth over $348,910. On average, John trades about 386 units every 39 days since 2007. As of 6 May 2015 John still owns at least 2,083 units of Exponent stock.
You can see the complete history of John Osteraas stock trades at the bottom of the page.
John's mailing address filed with the SEC is 149 COMMONWEATH DRIVE, , MENLO PARK, CA, 94025.
Over the last 21 years, insiders at Exponent have traded over $73,571,565 worth of Exponent stock and bought 2,000 units worth $170,360 . The most active insiders traders include Paul R Johnston, Richard L Jr Schlenker et John B Shoven. On average, Exponent executives and independent directors trade stock every 11 days with the average trade being worth of $675,547. The most recent stock trade was executed by Richard L Jr Schlenker on 31 July 2024, trading 40,662 units of EXPO stock currently worth $4,339,042.
exponent is an engineering and scientific consulting firm providing solutions to complex problems. whether the firm investigates an incident that happened in the past, or assists with the development of a new product or service, exponent offers knowledge to assist its clients make informed, intelligent decisions. exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and business today. the firm's consultants analyze failures and accidents to determine their causes and provide answers to help prevent such problems. in addition, exponent evaluates human health and environmental concerns to find cost-effective solutions. exponent’s staff of approximately 900, located in 20 offices throughout the nation and 6 international offices, combines unparalleled technical expertise with the ability, when necessary, to focus this knowledge in extreme
Exponent executives and other stock owners filed with the SEC include: